Category Archives: Prostate

Prostate MRI Reporting Template (Text)

Prostate MRI Reproving Template can be downloaded here:

PROSTATE MRI Reporting Template

PROSTATE MRI
==============
INDICATION: [High PSA, prior negative biopsy / Staging-treatment naive / Other]
PSA: [ ] ng/ml
PROSTATE VOLUME: [ ] cm SI x [ ] cm AP x [ ] cm LR  Vol= [ ]cc
PSA DENSITY: [ ] ng/ml/cc

====================================================================
LEGEND/Abbreviations:
====================================================================
Assessment Categories:
1 – Very low (clinically significant cancer is highly unlikely to be present)
2 – Low (clinically significant cancer is unlikely to be present)
3 – Intermediate (the presence of clinically significant cancer is equivocal)
4 – High (clinically significant cancer is likely to be present)
5 – Very high (clinically significant cancer is highly likely to be present)
Locations:
PZ = peripheral zone; TZ = transition zone
CZ=central zone; AFS = anterior fibromuscular stroma
a=anterior half (i.e. PZa=anterior half of peripheral zone);   pm= posterior medial (i.e PZpm)
pl = postero-lateral (i.e. PZpl);   p = posterior half (i.e. TZp) ;   a = anterior half (i.e TZa or PZa)
Other:
N=no or no; E= equivocal; Y=yes
EPE = extraprostatic extension
NVB = neurovascular bundle
NA = not applicable/not available
====================================================================

TECHNIQUE
Examination was performed using a [1.5 / 3]T MRI [without / with] an endorectal coil. Multiparametric imaging was performed with T2 mutliplanar sequences, axial diffusion weighted imaging and dynamic contrast enhanced imaging. Gadolinium based intravenous contrast agent was administered.

Pi-Rads v2:[Y / N]

IMAGE QUALITY: [Good / suboptimal but repeat not required / inadequate for diagnosis]

COMPARISON MRI: [ None / Date]

FINDINGS:
[There is no clinically significant cancer identified.]
Site 1:
Assessment Category:[1-5 ]
Size:[ ] mm x [ ] mm x [ ] mm
Location(s):[left/ right] [base / mid / apex] [ ]; Secondary Location:[left / right] [base / mid / apex] [ ]
NVB invasion: [Y/N]
EPE: [Y/N]

Site 2:
Assessment Category:[1-5 ]
Size:[ ] mm x [ ] mm x [ ] mm
Location(s):[left/ right] [base / mid / apex] [ ]; Secondary Location:[left / right] [base / mid / apex] [ ]
NVB invasion: [Y/N]
EPE: [Y/N]
Seminal vesicle invasion: [ ]
Abnormal lymph nodes: [ ]
Bone metastases in inferior pelvis: [ ]

IMPRESSION:
[A focus of clinically significant cancer is not identified.]
Highest Assessment Category: [1-5]
MRI Stage: T[0-4]  N[0-1]  M[0-1] based on review of pelvic images.
False negative rates for MRI range from 5-20% depending on risk profile.